Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4758300
Max Phase: Preclinical
Molecular Formula: C40H38ClFN6O5S
Molecular Weight: 769.30
Molecule Type: Unknown
Associated Items:
ID: ALA4758300
Max Phase: Preclinical
Molecular Formula: C40H38ClFN6O5S
Molecular Weight: 769.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(-c2c(-c3ccc(F)cc3)sc3ncnc(O[C@H](Cc4ccccc4OCc4cnccn4)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl
Standard InChI: InChI=1S/C40H38ClFN6O5S/c1-25-30(11-12-32(36(25)41)51-20-19-48-17-15-47(2)16-18-48)34-35-38(45-24-46-39(35)54-37(34)26-7-9-28(42)10-8-26)53-33(40(49)50)21-27-5-3-4-6-31(27)52-23-29-22-43-13-14-44-29/h3-14,22,24,33H,15-21,23H2,1-2H3,(H,49,50)/t33-/m1/s1
Standard InChI Key: SADZXBZFMGZHNM-MGBGTMOVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 769.30 | Molecular Weight (Monoisotopic): 768.2297 | AlogP: 7.20 | #Rotatable Bonds: 14 |
Polar Surface Area: 123.03 | Molecular Species: ACID | HBA: 11 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.00 | CX Basic pKa: 7.65 | CX LogP: 4.19 | CX LogD: 4.04 |
Aromatic Rings: 6 | Heavy Atoms: 54 | QED Weighted: 0.12 | Np Likeness Score: -1.06 |
1. Szlavik Z,Csekei M,Paczal A,Szabo ZB,Sipos S,Radics G,Proszenyak A,Balint B,Murray J,Davidson J,Chen I,Dokurno P,Surgenor AE,Daniels ZM,Hubbard RE,Le Toumelin-Braizat G,Claperon A,Lysiak-Auvity G,Girard AM,Bruno A,Chanrion M,Colland F,Maragno AL,Demarles D,Geneste O,Kotschy A. (2020) Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor., 63 (22): [PMID:33146521] [10.1021/acs.jmedchem.0c01234] |
Source(1):